Megestrol acetate for anorexia in patients with far-advanced cancer: A double-blind controlled clinical trial

European Journal of Cancer

Volumn 34, Issue 11, 1998, Pages 1705-1709

  De Conno, F ^a   Martini, C ^a   Zecca, E ^a   Balzarini, A ^a   Venturino, P ^a   Groff, L ^a   Caraceni, A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Advanced cancer; Anorexia; Cachexia; Megestrol acetate; Quality of life

Indexed keywords

MEGESTROL ACETATE;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HEALTH CARE COST; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OUTPATIENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANOREXIA; APPETITE; APPETITE STIMULANTS; CACHEXIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0032189512     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00219-6     Document Type: Article

References (22)

1. 1. Donnelly S, Walsh D, Rybicki L. Symptoms in advanced cancer. Semin Clin Oncol 1995, 26, 67-72.
2. 2. Bozzetti F, Agradi E, Ravera E. Anorexia in cancer patients: prevalence and impact on nutritional status. Clin Nutr 1989, 8, 35-43.
3. 3. Tisdale MJ. Cancer cachexia. Anticancer Drugs 1993, 4, 115-125.
4. 4. Loprinzi CL. Management of cancer anorexia/cachexia. Support Care Cancer 1995, 3, 120-122.
5. 5. Bruera E. Clinical management of anorexia and cachexia in patients with advanced cancer. Oncology 1992, 2, 35-42.
6. 6. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 1990, 66, 1279-1282.
7. 7. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990, 82, 1127-1132.
8. 8. Tchekmedyian NS, Hickman N, Siau J, Greco A, Aisner J. Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology 1990, 4, 185-192.
9. 9. Corli O, Cozzolino A, Battaiotto L, Bernoni M, Gallina A. A new method of food intake quantification: application to the care of cancer patients. J Pain Symptom Manage 1992, 7, 12-17.
10. 10. Tamburini M, Selmi S, De Conno F, Ventafridda V. Semantic descriptors of pain. Pain 1987, 29, 187-193.
11. 11. Tamburini M, Rosso S, Gamba A, Mencaglia E, De Conno F, Ventafridda V. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 1992, 3, 565-570.
12. 12. Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J Chronic Dis 1987, 40, 939-942.
13. 13. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945, 1, 80-83.
14. 14. Fisher RA. Statistical Methods for Research Workers. Edinburgh, Oliver and Boyd, 1934.
15. 15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. I Introduction and design. Br J Cancer 1976, 34, 585-612.
16. 16. Gillings D, Koch G. The application of the principle of intention to treat to the analysis of clinical trials. Drug Info J 1991, 25, 411-424.
17. 17. O'Shaughnessy JA, Wittes RE, Burke G, et al. Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trial. J Clin Oncol 1991, 9, 2225-2232.
18. 18. Caraceni A, De Conno F. Analgesic effects of chemotherapy? (letter) J Clin Oncol 1998, 16, 803.
19. 19. Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J. Symptomatic effects of megestrole acetate (MA): a double blind cross-over study. Proc Am Soc Clin Oncol 1996, 15, 531.
20. 20. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993, 11, 762-767.
21. 21. Tchekmedyian NS, Hickman M, Siau J, et al. Megestrol acetate in cancer anorexia and weight loss. Cancer 1992, 69, 1268-1274.
22. 22. Feliu J, Gonzalez BM, Berrocal A, et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study. Am J Clin Oncol 1992, 15, 436-440.